Summary & Overview
CPT 77022: MR Guidance and Monitoring for Parenchymal Tissue Ablation
CPT code 77022 denotes MR imaging guidance and monitoring for the localization and ablation monitoring of parenchymal tissues. Nationally, the code matters because MR-guided ablation is a precision imaging service used in minimally invasive oncologic and non-oncologic procedures; accurate reporting separates the imaging guidance from the therapeutic ablation and affects facility and professional billing. Key payers in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare.
Readers will find a concise overview of the code’s clinical context and common service settings, an explanation of what is reported under the code (MR imaging guidance and real-time monitoring only), and what typical billing practice distinguishes this imaging service from the ablative procedure itself. The publication outlines typical site-of-service considerations and common modifiers used in practice. Where available, benchmarking material and payer coverage trends are summarized to inform coding and billing workflows, and policy updates relevant to MR-guided ablation imaging are highlighted. Data not available in the input will be noted as such.
Billing Code Overview
CPT code 77022 describes magnetic resonance (MR) imaging guidance and monitoring used to locate parenchymal tissues and to monitor their ablation. This code is reported when the provider performs MR imaging guidance and real-time monitoring for an ablation procedure; it represents the imaging component only and does not include the ablative treatment itself.
Service type: Imaging guidance and monitoring for ablation procedures
Typical site of service: Hospital outpatient department or ambulatory surgical center, where MR-guided ablation procedures are commonly performed.
Clinical & Coding Specifications
Clinical Context
A 62-year-old patient with a solitary 2.5 cm hepatic tumor (suspected hepatocellular carcinoma or metastatic lesion) is scheduled for percutaneous tumor ablation under magnetic resonance imaging (MRI) guidance. The clinical workflow begins with pre-procedure evaluation including review of prior imaging (CT/MRI), laboratory testing (coagulation profile, CBC, liver function tests), and informed consent. On the day of the procedure the patient is positioned in the MRI suite; IV access and monitoring are established; sedation or anesthesia is provided per anesthesiology or interventional radiology protocol. The interventional team uses real-time MRI to plan needle trajectory into the parenchymal tissue, confirm accurate placement of the ablation probe, and continuously monitor ablation extent to ensure margin adequacy and avoid adjacent critical structures. Post-ablation MRI sequences assess immediate treatment effect and exclude complications such as hemorrhage or thermal injury. The provider documents MRI guidance and monitoring only when no separate imaging interpretation or therapeutic procedure reporting overlaps this code.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
26 | Professional component | Use when only the interpreting physician’s professional work is reported for the MRI guidance/monitoring service. |
52 |